Company Quick10K Filing
Taylor Morrison Home
10-Q 2021-03-31 Filed 2021-04-29
10-K 2020-12-31 Filed 2021-02-24
10-Q 2020-09-30 Filed 2020-11-02
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-10-30
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-02-20
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-02
10-K 2017-12-31 Filed 2018-02-21
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-21
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-05
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-02-24
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
8-K 2020-10-28
8-K 2020-09-03
8-K 2020-07-30
8-K 2020-07-22
8-K 2020-07-08
8-K 2020-07-08
8-K 2020-05-28
8-K 2020-05-06
8-K 2020-04-08
8-K 2020-02-28
8-K 2020-02-06
8-K 2020-02-06
8-K 2020-02-05
8-K 2020-01-31
8-K 2020-01-30
8-K 2020-01-27
8-K 2020-01-23
8-K 2020-01-17
8-K 2020-01-03
8-K 2019-12-18
8-K 2019-12-05
8-K 2019-12-05
8-K 2019-11-05
8-K 2019-11-05
8-K 2019-10-30
8-K 2019-08-01
8-K 2019-07-31
8-K 2019-07-18
8-K 2019-07-18
8-K 2019-06-05
8-K 2019-05-29
8-K 2019-05-21
8-K 2019-05-01
8-K 2019-03-11
8-K 2019-02-13
8-K 2019-02-01
8-K 2018-11-21
8-K 2018-10-31
8-K 2018-10-15
8-K 2018-10-02
8-K 2018-09-19
8-K 2018-08-01
8-K 2018-07-18
8-K 2018-06-29
8-K 2018-06-14
8-K 2018-06-07
8-K 2018-06-07
8-K 2018-05-30
8-K 2018-05-02
8-K 2018-02-07
8-K 2018-01-26
8-K 2018-01-11
8-K 2018-01-11
8-K 2018-01-03

Taylor Morrison Home Financials

TMHC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash238421355389433301282234400146158126141132161300302248266576289321383332174198224
Accounts Receivable
Inventory
PP&E66715788556677667666739393887858584
Assets2,7783,2553,4023,4393,7343,9134,0334,1333,8703,8794,1224,1374,2504,2314,2704,2214,1494,2584,3174,3264,0844,2214,3325,2645,1905,1785,340
Accounts Payable0
Long-Term Debt1,4411,4781,5881,7371,5721,5501,7001,6831,8061,7411,6991,5991,4751,4661,4731,5081,4151,4361,4652,2102,1402,0922,131
Liabilities1,5571,8401,9281,8942,1612,2712,3422,3562,0192,0072,2022,1652,2542,2062,1862,0611,9511,9972,0031,9791,8881,9621,9722,8462,7952,7752,854
Stockholders' Equity1,2211,4161,4741,5451,5744424554784985045175205225155275529521,3441,3741,5962,1752,2372,3332,4152,3912,3992,480
Income Statement ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue7981,0129701,1971,3009811,0361,4589251,2651,105
Cost of Revenue6148087839741,0458028371,2407531,032894
Gross Profit8210513418511314015320495137149187119160179223142171171254143179199217172234211
R&D
SG&A46605968586569595771798777918810589959511187100101104125119
Tax16-2632-713242712221022364222324119442426122023172823
Net Income2451426115566289720461826465919365655204859949518267
Cash Flow ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-53-241-44186-246-20-170-123219-178277230148-483325311046-281748
Cash Investing-1-1-4-70-2-48296-79-158-10-69-4-2-7-14-7-5-10-426-43-6
Cash Financing-4435-23-6929930-169-52150-32100-87-46-84-1331-965-2832010-126-15224